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Abstract
Introduction: Adequate planning and implementation of stroke systems of care is key to guarantee a rapid healthcare
response and delivery of specific reperfusion therapies among candidates. We assessed the availability of stroke care
plans in Europe, and evaluated their impact on rates of reperfusion therapies for stroke.
Patients: Based on the European Stroke Organisation (ESO), the European Society of Minimally Invasive Neurological
Therapy (ESMINT), the European Academy of Neurology (EAN), and the Stroke Alliance for Europe (SAFE) survey, we
analysed specific prespecified items in the questionnaire regarding availability and adequacy of stroke care plans, organ-
ised prehospital care and their potential impact on rates of delivery of reperfusion therapies for stroke at the coun-
try level.
Results: Of 44 participating European countries, 37 have stroke care plans that operate at national and/or regional
levels. Most stroke care plans take responsibility for the organisation/implementation of stroke systems of care (86%),
quality of care assessment (77%), and act as a liaison between emergency medical systems and stroke physicians (79%).
As for stroke systems of care, the focus is mainly on prehospital and in-hospital acute stroke care (Code Stroke systems
available in 37/44 countries). Preferred urgent transport is via non-medicalised ambulances (70%). Presence of stroke
care plans, stroke registry data, transport of urgent stroke patients via non-medicalised ambulances, and drip-and-ship
routing of acute patients showed higher reperfusion treatment rates.
Discussion: Availability of stroke care plans, still absent in some European countries, as well as some features of the
stroke systems of care are associated with higher reperfusion treatment rates.
Conclusion: Stroke is not yet a priority everywhere in Europe, which is a barrier to the spread of reperfusion therapies
for stroke.
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Large disparities in health exist across and within
European countries,1,2 and raising awareness of these
health inequalities as well as supporting the develop-
ment of transnational policies to address them is key to
shorten the gap between evidence and practice. In 2017,
the publication The Burden of Stroke in Europe by the
Stroke Alliance for Europe (SAFE) suggested a 34%
increase in stroke incidence by 2035, a 45% increase of
stroke deaths, and a 25% increase of stroke survivors
living with the consequences of stroke.3 To mitigate the
increase in stroke burden, SAFE called EU policy
makers to support a joint action on stroke, addressing
– among others – topics such as data collection, pro-
motion and implementation of national stroke strate-
gies, and performance assessment. To achieve this,
ESO in collaboration with SAFE developed the
Action Plan for Stroke in Europe 2018–2030.4
At the national level, concerns of health authorities
on the abovementioned projections have translated
into the establishment of stroke care plans, strategies,
guidelines and programmes of action. To maximise the
numbers of acute stroke patients accessing specific
reperfusion therapies, stroke care plans have mainly
focused on the implementation of organised systems
of care that aim to ease rapid access of acute stroke
patients to stroke unit (SU) care and such therapies.
However, it is unknown to what extension this is true
for European countries, what the main lines of action
of stroke care plans are, how acute stroke care is organ-
ised, etc. Therefore, the objective of this study is to
describe the situation among European countries in
relation to stroke planning, stroke care organisation
and to explore their association with reperfusion treat-
ment rates.
Methods
Study design and participants
This study is based on data from a pan-European
survey conducted among European chairs of national
stroke societies and stroke experts. The survey’s steer-
ing committee consisted of 10 representatives from the
European Stroke Organisation (ESO), the European
Society of Minimally Invasive Neurological Therapy
(ESMINT), the European Academy of Neurology
(EAN) and the Stroke Alliance for Europe (SAFE),
including at least one board member from each society.
The World Health Organization (WHO) definition of
the European region consisting of 51 countries was
adopted. Countries with less than 100,000 inhabitants
(Monaco, Liechtenstein, Andorra, and San Marino)
were excluded, and North Cyprus, which was not
listed under the WHO definition, was added. Details
of the survey have been described in depth elsewhere.5
Briefly, the survey consisted of 64 items organised into
five sections corresponding to: (1) organisation of
stroke systems of care, (2) prehospital stroke care, (3)
specific stroke treatment, (4) stroke registries and qual-
ity control, and (5) stroke awareness campaigns. This
study focuses on contents of this section and the pre-
vious section.
Coordinators and experts from 44 European coun-
tries (see Appendix 1 for the list of collaborators) were
responsible for identifying the most reliable and recent
national data sources (i.e. stroke registries, governmen-
tal data sources) to answer the survey questions. In the
absence of national or local stroke registries, the coor-
dinator and experts were asked to perform best esti-
mates by consensus and took full responsibility for
the validity of the responses provided.
Data collection
The survey was announced through ESO, ESMINT
and EAN newsletters six months before it started,
and finally performed between 30 October 2016 and
24 February 2017. A draft version of the survey was
externally reviewed by four stroke experts (see,
Acknowledgments) with extensive research skills and
proven experience in drafting European stroke surveys.
A pilot feasibility survey was accomplished in Austria,
Hungary, Poland, Spain and Switzerland.
Data analyses
Our analyses focused on the planning and organisation
of stroke systems of care, including prehospital care.
All data were analysed using appropriate descriptive
methods. Intravenous thrombolysis (IVT) and endo-
vascular treatment (EVT) rates were compared
between groups using the Kruskall–Wallis test by
ranks. Number of residents per country, and
population-based IVT and EVT rates were derived
from the original paper.5
Results
Overall, 44 of 51 invited countries participated in the
survey (response rate: 86%). Among the 44 respond-
ents, with an overall population of about 835 millions,
the absolute number of incident strokes ranged from
240 to 250,000 cases/year. In 37 (86.1%) out of 44 coun-
tries, there was a stroke care plan, which in most coun-
tries operated at the national and/or regional level
(national only: 20, regional only: 3, and both: 11 coun-
tries). In six other countries (Croatia, Kyrgyzstan,
Belarus, Greece, Romania, Ukraine), the stroke care
plan operated at a local level. There were no differences
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300,000 3355 No Region only Yes 5 Yes
Iceland 333,000 102,775 Yes Country only No – Yes
Malta 420,000 316 Yes Country only Yes 2 Yes
Montenegro 621,000 13,812 Yes Country only No – No
Overall 418,500 30,065 75% 75% country only 50% 75%
25% region only
1–10 million Estonia 1,325,000 45,339 Yes Country only No – No
Latvia 1,800,000 64,589 Yes Neither Yes 6 No
Macedonia 2,000,000 25,713 Yes Country only Yes 4 Yes
Slovenia 2,065,000 20,273 Yes Both Yes 12 No
Lithuania 3,000,000 65,300 Yes Country only Yes 5 No
Albania 3,100,000 28,748 Yes Region only No – Yes
Bosnia and
Herzegovina
3,517,000 51,129 No Both Yes 11 Yes
Republic of
Moldova
3,600,000 33,846 Yes Country only No – No
Georgia 3,700,000 2428 Yes Neither No – Yes
Croatia 4,171,000 56,594 Yes Local No – Yes
Ireland 4,800,000 70,273 Yes Country only No – Yes
Norway 5,000,000 385,178 Yes Both Yes 5 No
Slovakia 5,400,000 49,036 Yes Country only No – Yes
Finland 5,495,000 338,145 Yes Both Yes 21 Yes
Denmark 5,600,000 44,493 Yes Country only Yes 5 No
Kyrgyzstan 6,000,000 199,949 No Local Yes 7 Yes
Bulgaria 7,000,000 110,994 Yes Both Yes 28 Yes
Switzerland 8,081,000 41,290 Yes Country only Yes 8 No
Israel 8,100,000 20,770 Yes Country only No – Yes
Austria 8,700,000 83,858 Yes Both Yes 9 No
Serbia 8,800,000 77,453 Yes Country only Yes – Yes






10–20 million Sweden 10,000,000 449,964 Yes Both Yes 20 Yes
Belarus 10,000,000 207,600 Yes Local Yes 1 Yes
Hungary 10,000,000 93,030 Yes Country only No – Yes
Greece 10,000,000 13,194 No Local No – Yes
Portugal 10,460,000 91,568 Yes Country only Yes 6 Yes
Czech Republic 10,500,000 78,866 Yes Country only No – No
Belgium 11,350,000 30,510 No Neither Yes 3 Yes
Netherlands 17,000,000 41,198 Yes Both No – No
Romania 19,500,000 238,392 Yes Local No – Yes





>20 million Poland 38,000,000 312,685 Yes Country only Yes 16 Yes
Ukraine 42,500,000 603,628 No Local Yes 24 Yes
Spain 46,560,000 498,468 Yes Both Yes 17 Yes
(continued)
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regarding stroke care plan level (country-, region-,
both-, and none) by size of country population
(Table 1). As for the specific aims of the respective
stroke care plans, involvement in stroke care quality
improvement initiatives (n¼ 33), organising and imple-
menting stroke systems of care (n¼ 37), and leading
Emergency Medical Systems involvement (EMS) and
their cooperation with stroke physicians (n¼ 34) were
the most common goals (Figure 1). Across Europe,
stroke care plans were not always comprehensive, and
often they did not approach the whole continuum of
stroke care. However, stroke care plans most common-
ly focused on the initial Emergency Room admission
and the acute hospital management of stroke patients
(41 and 43 countries, respectively). In line with this, in
37 out of 44 European countries there existed a Code
Stroke protocol with involvement of the EMS. In 2/3 of
countries, the Code Stroke was supported by an
instruction; that is, an official document that estab-
lishes the territorial compartmentalisation and opera-
tional criteria. The protocol is activated whenever
sudden neurological impairment suggesting a stroke is
identified, and common constraints to code stroke acti-
vation included late presentation after symptoms onset
(59%) and premorbid disability (28%). Most EMS
protocols implied transporting acute stroke patients
in non-medicalised (staffed with technicians) ambulan-
ces (70%) but medicalised ambulances (staffed with a
general physician and a nurse) were also available in


















Italy 60,750,000 301,318 Yes Region only Yes 21 Yes
United Kingdom 65,640,000 244,820 Yes Country only Yes 4 No
France 66,900,000 551,394 Yes Both Yes 17 No
Turkey 78,740,000 23,507 Yes Both No – –
Germany 82,670,000 357,168 Yes Country only Yes 300 Yes
Russia 146,000,000 3,972,400 Yes Country only No – No























































































































Figure 1. Distribution of main activity lines of Stroke Care Plans across European countries. Numbers express n of countries
including that activity.
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line carrier or as a second-line resource used in specific
clinical conditions. Availability of mobile SUs was
only limited.
The relationship between availability of stroke care
plans, their characteristics and the reperfusion treat-
ment rates is shown in Table 2. National stroke registry
data were only available in 16 (36.4%) countries.
Countries having registry data available showed
higher treatment rates per million inhabitants (IVT:
211 vs. 93; EVT: 49 vs. 10). Similarly, countries with
a stroke care plan had higher treatment rates (IVT: 140
vs. 30; EVT: 39 vs. 8), which was directly associated
with the stroke care plan action level (an increase in
treatment rates from local to country level). Moreover,
stroke care plans focusing specifically on health care
planning, quality improvement, centralised registries
and community education activities were associated
with higher treatment rates (Table 2). As for the orga-
nisation of urgent prehospital stroke care, routine use
of non-medicalised ambulances (as compared to medi-
calised ambulances), and strict orders to transfer acute
patients to the nearest centre providing IVT also
showed significantly higher rates of both IVT (non-
medicalised ambulances: 147 per 100,000 inhabitants-
year, p value <0.01; EMS strict transfers: 159 per
100,000 inhabitants-year, p value¼ 0.001), and EVT
(non-medicalised ambulances: 49 per 100,000
inhabitants-year, p value¼ 0.05, and EMS strict trans-
fers: 48 per 100,000 inhabitants-year, p value¼ 0.008).
Application of a ‘by-pass local stroke centre’ rule
Table 2. Association between Stroke Plans features, system of care coverage and reperfusion treatment rates.
N countries
IVT rate per 106
inhabitants-year,
median (IQR) p value
EVT rate per 106
inhabitants-year,
median (IQR) p value
Overall 42 122 (39–211) 34 (4–71)
Registry data 14 211 (124–288) 0.008 49 (37–74) 0.085
No registry data 28 93 (20–176) 10 (2–64)
Stroke Plan (active) 36 140 (64–254) 0.042 39 (5–72) 0.202
No Stroke Plan (active) 6 30 (7–96) 8 (0–63)
Stroke Plan level
Country level 31 149 (81–266) 0.008 45 (5–74) 0.021
Region level 14 129 (41–266) 0.584 46 (13–69) 0.274
Local level 13 39 (11–149) 0.021 6 (4–37) 0.064
Stroke Plan duties
Health planning 23 168 (117–285) <0.001 48 (27–74) 0.005
Quality assessment 32 154 (93–270) 0.005 49 (5–73) 0.008
Reimbursement 15 159 (81–243) 0.194 40 (6–71) 0.243
Organisation 36 140 (49–254) 0.052 42 (5–72) 0.114
Registries 21 168 (117–288) 0.001 48 (29–74) 0.027
Community education 25 194 (96–274) 0.002 52 (27–74) 0.006
Emergency 33 124 (57–199) 0.444 40 (5–71) 0.108
Cost analysis 11 168 (117–274) 0.179 40 (6–71) 0.731
Professional education 27 147 (57–266) 0.281 45 (5–75) 0.083
Stroke system of care coverage
Stroke prevention 17 211 (149–288) <0.001 52 (32–74) 0.005
Emergency admission 40 129 (48–227) 0.125 39 (4–71) 0.156
Acute hospital care 43 – – –
Neurorehabilitation 28 140 (64–270) 0.081 30 (5–75) 0.251
Post-stroke care 17 159 (96–285) 0.037 40 (13–74) 0.027
Non-medicalised ambulance only 19 147 (96–266) 0.007 49 (27–74) 0.052
Medicalised ambulance 23 71 (19–134) 6 (1–63)
EMS strict transfers 29 159 (91–274) 0.001 48 (7–72) 0.008
No EMS strict transfers 13 21 (7–121) 4 (0–37)
EMS stroke protocol 28 164 (93–270) 0.004 42 (5–71) 0.268
No EMS protocol 14 36 (11–121) 6 (2–64)
‘By-pass local hospital’ policy 6 267 (117–351) 0.062 75 (45–96) 0.018
No ‘By-pass local hospital’ policy 36 115 (30–196) 28 (2–64)
IQR: interquartile range.
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according to patient’s baseline features (large vessel
occlusion stroke suspicion) showed higher EVT rates
(75 per 100,000 inhabitants-year, p value¼ 0.018).
Discussion
This study shows that there is still a considerable pro-
portion of European countries without an appropriate
Stroke Strategy or Plan, something that is unfortunate-
ly pointing at the low priority that health care decision
makers give to stroke in these countries. After two Pan-
European Consensus Conferences on Stroke
Management, 1995 and 2006,6,7 and despite the very
recent European Stroke Action Plan (ESAP),4 there
still is a long way to go. Health authorities and decision
makers should include stroke in their priority agendas
since stroke is the second leading cause of death in
European countries, and the most common cause of
permanent, non-traumatic disability in adults.8
Turning stroke burden around requires a multifaceted
approach that begins with its inclusion in the political
agendas. The creation of stroke care plans that operate
at national and/or regional level is not enough but a
good start. In line with this, availability of valid regis-
try data (currently, only 1/3 of respondents have it) is
of utmost importance to keep track of stroke incidence,
sociodemographic characteristics, access of residents to
evidence-based therapies for acute ischaemic stroke,
quality metrics and outcome measurements. Only
through high quality registry data, achievements and
improvements can be properly monitored. In these
regards, it is reassuring that the current study shows
significantly higher reperfusion treatment rates in coun-
tries with stroke care plans and registry data available.
Importantly, this is not to say that there is a cause–
effect relationship between stroke care plans and reper-
fusion treatment rates, something that would need a
completely different methodological approach.
It might be expected that large and highly populated
countries should have both national stroke strategies
and regional stroke care plans where operational
aspects of care, including organisation of acute stroke
care, are dealt with. However, such association was not
seen in this study, something that might be explained
by differences in the territorial and political organisa-
tion within each country. Most stroke care plans take
responsibility for quality of stroke care assessment and
organisation of Code Stroke systems with involvement
of EMS. Such systems were initially developed during
the thrombolytic era to get over the therapeutic nihil-
ism, and to achieve that as many acute ischaemic stroke
patients as possible were eventually treated. More
recently, demonstration of the efficacy of mechanical
thrombectomy is prompting systems of care to adapt to
the new reality and streamline the process of care even
more. Not only quick on-scene recognition of sus-
pected strokes is necessary but also in-hospital process-
es must be sped up to shorten the door-in door-out
time that allows handover between hospitals. Thus, in
most countries, the focus is clearly on acute stroke care,
and the post-acute care and rehabilitation phase are
aspects of care often not included. Though perhaps
satisfactory for stroke and emergency physicians,
organising stroke systems of care from that perspective
only is insufficient. In that sense, the ESAP includes
targets for a series of domains in stroke care: organisa-
tion of stroke services, management of acute stroke,
prevention, rehabilitation, evaluation of stroke out-
come and quality assessment. ESAP also includes two
additional domains, on primary prevention and life
after stroke, along with research and development pri-
orities for translational stroke research.9
The major limitation of this study is that it relied on
self-reported surveyed data. Even though stroke nation-
al (or regional, if relevant) contacts were asked to pro-
vide only best available information to compile the
survey, in countries lacking stroke registries multiple
sources of regional and local information were used to
extrapolate national figures and, therefore, the informa-
tion returned might not be that precise. In addition, no
audit could be performed to assess the quality of the
data. Another limitation of this study is that we sur-
veyed and performed the analyses at the country level.
Efforts were made to take into consideration the regions
perspectives in countries where regions play an impor-
tant role in health policymaking or where health budged
is devolved. However, national survey coordinators
were asked to aggregate regions’ responses at the nation-
al level. Thus, this study does not properly reflect the
situation of those regions with a distinctive stroke care
plan that are embedded in large countries with huge
variation across regions. Another aspect that should
be born in mind is the restricted number of outcome
variables included (i.e. number of IVT and EVT/coun-
try/year, which were worked out to produce population
treatment rates), which are insufficient to assess the
impact and quality of Stroke Plans and prehospital
stroke care. In this context, it would be especially impor-
tant to link respective treatment rates with actual patient
outcomes as the ultimate goal of all our efforts.
Nevertheless, the study is relevant because it encom-
passes a thorough pan-European perspective that
serves to identify organisational shortcomings in a
number of countries: most importantly, absence of pri-
ority for stroke in some health systems that translates
into poor planning and organisation of stroke systems
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of care, poor community education, lack of registry data
and eventually a hindered access to evidence-based ther-
apies. In this respect ‘organisation is also curative’, par-
ticularly in diseases where time counts, that is, which
require quick and smooth transitions between care
levels, and cooperation of relevant professionals from
different fields as is the case with stroke.
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